Figure 2. Percentage of Patients Achieving vIGA-AD Success and at Least 75% Improvement in EASI Score.

Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) was evaluated on a 5-point scale: 0 (clear), 1 (almost clear), 2 (mild), 3 (moderate), and 4 (severe). vIGA-AD success was defined as a score of 0 or 1 plus at least a 2-grade improvement from baseline. EASI-75 indicates at least a 75% reduction in Eczema Area and Severity Index score from baseline.

^aP values are nominal.